SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001689813-22-000064
Filing Date
2022-08-05
Accepted
2022-08-05 16:13:14
Documents
97
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bhvn-20220630.htm   iXBRL 10-Q 2402745
2 EX-31.1 a2022q2bhvn10-qexhibit311.htm EX-31.1 10525
3 EX-31.2 a2022q2bhvn10-qexhibit312.htm EX-31.2 10739
4 EX-32.1 a2022q2bhvn10-qexhibit321.htm EX-32.1 7601
10 GRAPHIC bhvn-20220630_g1.jpg GRAPHIC 23128
11 GRAPHIC bhvn-20220630_g2.jpg GRAPHIC 85295
  Complete submission text file 0001689813-22-000064.txt   12630696

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20220630.xsd EX-101.SCH 91207
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhvn-20220630_cal.xml EX-101.CAL 111599
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhvn-20220630_def.xml EX-101.DEF 444323
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20220630_lab.xml EX-101.LAB 963445
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20220630_pre.xml EX-101.PRE 667545
91 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20220630_htm.xml XML 2466093
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38080 | Film No.: 221140982
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences